Vitamin D in the development and progression of alzheimer’s disease: implications for clinical management

References

• 2020 Alzheimer’s disease facts and figures [published online ahead of print, 2020 Mar 10]. Alzheimers Dement. 2020. 10.1002/alz.12068.
   Google Scholar
• Livingston G, Huntley J, Sommerlad A, et al., Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 396(10248): 413–446. 2020. .
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub; 2013. https://play.google.com/store/books/details?id=-JivBAAAQBAJ
   Google Scholar
• Del Parigi A, Panza F, Capurso C, et al. Nutritional factors, cognitive decline, and dementia. Brain Res Bull. 2006;69(1):1–19. .
   PubMed Web of Science ®Google Scholar
• Kimura A, Sugimoto T, Kitamori K, et al. Malnutrition is associated with behavioral and psychiatric symptoms of dementia in older women with mild cognitive impairment and early-stage Alzheimer’s disease. Nutrients. 2019;11(8):E1951. .
   PubMed Web of Science ®Google Scholar
• Hersi M, Irvine B, Gupta P, et al. Risk factors associated with the onset and progression of Alzheimer’s disease: a systematic review of the evidence. Neurotoxicology. 2017;61:143–187.
   PubMed Web of Science ®Google Scholar
• WHO. Risk reduction of cognitive decline and dementia: WHO guidelines. Geneva: World Health Organization; 2019.
   Google Scholar
• Zhao C, Tsapanou A, Manly J, et al. Vitamin D intake is associated with dementia risk in the washington heights-inwood columbia aging project (WHICAP). Alzheimers Dement. 2020;16:1393–1401.
   PubMed Web of Science ®Google Scholar
• Annweiler C, Allali G, Allain P, et al. Vitamin D and cognitive performance in adults: A systematic review. Eur J Neurol. 2009;16(10):1083–1089. .
   PubMed Web of Science ®Google Scholar
• Annweiler C, Schott AM, Allali G, et al., Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology. 74(1): 27–32. 2010. .
   PubMed Web of Science ®Google Scholar
• Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med. 2010;170(13):1135–1141. .
   PubMed Web of Science ®Google Scholar
• Slinin Y, Paudel M, Taylor BC, et al. Study of osteoporotic fractures research group. Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women. J Gerontol A Biol Sci Med Sci. 2012;67(10):1092–1098. for the. .
   PubMed Web of Science ®Google Scholar
• Solfrizzi V, Agosti P, Lozupone M, et al. Nutritional intervention as a preventive approach for cognitive-related outcomes in cognitively healthy older adults: a systematic review. J Alzheimers Dis. 2018;64(s1):S229–54. .
   PubMed Web of Science ®Google Scholar
• Anjum I, Jaffery SS, Fayyaz M, et al. The role of vitamin d in brain health: A mini literature review. Cureus. 2018;10:e2960.
   PubMed Web of Science ®Google Scholar
• Patel P, Shah J. Role of Vitamin D in Amyloid clearance via LRP-1 upregulation in Alzheimer’s disease: A potential therapeutic target? J Chem Neuroanat. 2017;85:36–42.
   PubMed Web of Science ®Google Scholar
• Lund J, DeLuca H. Biologically active metabolite of vitamin D3 from bone, liver and blood serum. J Lipid Res. 1969;7:739–744.
   Google Scholar
• Holick MF. Vitamin D: photobiology metabolism and clinical applications. In: DeGroot L, Besser H, HG B, editors. Endocrinology. Vol. third. Philadelphia: WB Saunders; 1995. p. 990–1013.
   Google Scholar
• Crescioli C. Targeting age-dependent functional and metabolic decline of human skeletal muscle: the geroprotective role of exercise, myokine il-6, and vitamin D. Int J Mol Sci. 2020;ì21(3):ì1010.
   Google Scholar
• Haussler MR, Whitfield GK, Haussler CA, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998;13(3):325–349. .
   PubMed Web of Science ®Google Scholar
• Control of Gene Expression by Vitamin D Receptor. Available at: https://data.broadinstitute.org/gseamsigdb/msigdb/biocarta/human/h_vdrPathway.gif (last accessed: 2020 Dec 18).
   Google Scholar
• Lukaszyk E, Bien-Barkowska K, Bien B. Cognitive functioning of geriatric patients: is hypovitaminosis D the next marker of cognitive dysfunction and dementia? Nutrients. 2018;10(8):1104.
   PubMed Web of Science ®Google Scholar
• Laughlin GA, Kritz-Silverstein D, Bergstrom J, et al. Vitamin D insufficiency and cognitive function trajectories in older adults: the Rancho Bernardo Study. J Alzheimers Dis. 2017;58(3):871–883. .
   PubMed Web of Science ®Google Scholar
• Annweiler C. Vitamin D in dementia prevention. Ann N Y Acad Sci. 2016;1367(1):57–63.
   PubMed Web of Science ®Google Scholar
• Karakis MP, Pase A, Beiser A, et al. Association of serum vitamin D with the risk of incident dementia and subclinical indices of brain aging: the Framingham heart study. J Alzheimers Dis. 2016;51(2):451–461. .
   PubMed Web of Science ®Google Scholar
• Jain SK, Micinski D. Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes. Biochem Biophys Res Commun. 2013;437(1):7–11.
   PubMed Web of Science ®Google Scholar
• DeLuca GC, Kimball SM, Kolasinski J, et al., Review: the role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol. 39(5): 458–484. 2013. .
   PubMed Web of Science ®Google Scholar
• Ibi M, Sawada H, Nakanishi M, et al. Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology. 2001;40(6):761–771. .
   PubMed Web of Science ®Google Scholar
• Latimer CS, Brewer LD, Searcy JL, et al. Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats. Proc Natl Acad Sci U S A. 2014;111(41):E4359–66. .
   PubMed Web of Science ®Google Scholar
• Nissou MF, Guttin A, Zenga C, et al. Additional clues for a protective role of vitamin D in neurodegenerative diseases: 1,25-dihydroxyvitamin D3 triggers an anti-inflammatory response in brain pericytes. J Alzheimers Dis. 2014;42(3):789–799. .
   PubMed Web of Science ®Google Scholar
• Lin CI, Chang YC, Kao NJ, et al. 1,25(OH)2D3 alleviates aβ(25-35)-induced tau hyperphosphorylation, excessive reactive oxygen species, and apoptosis through interplay with glial cell line-derived neurotrophic factor signaling in SH-SY5Y cells. Int J Mol Sci. 2020;21(12):4215. .
   Web of Science ®Google Scholar
• AlJohri R, AlOkail M, Haq SH. Neuroprotective role of vitamin D in primary neuronal cortical culture. eNeurological Sci. 2019;14:43–48.
   PubMedGoogle Scholar
• Banakar MC, Paramasivan SK, Chattopadhyay MB, et al. 1α, 25-dihydroxyvitamin D prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital. World J Gastroenterol. 2004;10(9):1268–1275. .
   PubMed Web of Science ®Google Scholar
• Daneshkhah A, Agrawal V, Eshein A, et al. The possible role of vitamin D in suppressing cytokine storm and associated mortality in COVID-19 patients. MedRxiv. 2020. [preprint]. 10.1101/2020.04.08.20058578.
   Google Scholar
• LK AML, LA L, PE ADA, et al. Vitamin D (VD3) antioxidative and anti-inflammatory activities: peripheral and central effects. Eur J Pharmacol. 2020;879:173099.
   PubMed Web of Science ®Google Scholar
• Xu Y, Baylink DJ, Chen CS, et al. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J Transl Med. 2020;18(1):322. .
   PubMed Web of Science ®Google Scholar
• Panza F, Lozupone M, Solfrizzi V, et al. BACE inhibitors in clinical development for the treatment of Alzheimer’s disease. Expert Rev Neurother. 2018;18(11):847–857. .
   PubMed Web of Science ®Google Scholar
• Guo YX, He LY, Zhang M, et al. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Abeta1-40 brain-to-blood efflux and peripheral uptake transport. Neuroscience. 2016;322:28–38.
   PubMed Web of Science ®Google Scholar
• Mizwicki MT, Menegaz D, Zhang J, et al. Genomic and nongenomic signaling induced by 1alpha,25(OH)2-vitamin D3 promotes the recovery of amyloid-beta phagocytosis by Alzheimer’s disease macrophages. J Alzheimers Dis. 2012;29(1):51–62. .
   PubMed Web of Science ®Google Scholar
• Moretti R, Morelli ME, Caruso P. Vitamin D in neurological diseases: a rationale for a pathogenic impact. Int J Mol Sci. 2018;19(8):2245.
   Web of Science ®Google Scholar
• Alamro AA, Alsulami EA, Almutlaq M, et al. Therapeutic potential of vitamin D and curcumin in an in vitro model of Alzheimer Disease. J Cent Nerv Syst Dis. 2020;12:1179573520924311.
   Web of Science ®Google Scholar
• Clinical development plan: curcumin.J Cell Biochem. Suppl.1996;26:72–85. [No authors listed].
   PubMedGoogle Scholar
• Masoumi A, Goldenson B, Ghirmai S, et al. 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer’s disease patients. J Alzheimers Dis. 2009;17(3):703–717. .
   PubMed Web of Science ®Google Scholar
• Eyles D, Brown J, Mackay-Sim A, et al. Vitamin D3 and brain development. Neuroscience. 2003;118(3):641–653. .
   PubMed Web of Science ®Google Scholar
• Feron F, Burne THJ, Brown J, et al. Developmental vitamin D3 deficiency alters the adult rat brain. Brain Res Bull. 2005;65(2):141–148. .
   PubMed Web of Science ®Google Scholar
• Sadi G, Konat D. Resveratrol regulates oxidative biomarkers and antioxidant enzymes in the brain of streptozotocin-induced diabetic rats. Pharm Biol. 2016;54(7):1156–1163.
   PubMed Web of Science ®Google Scholar
• Torres P-U, Prie D, Molina-Bletry V, et al. Klotho: an antiaging protein involved in mineral and vitamin D metabolism. Kidney Int. 2007;71(8):730–737. .
   PubMed Web of Science ®Google Scholar
• Kuro-o M. Klotho and aging. Biochim Biophys Acta. 2009;1790(10):1049–1058.
   PubMed Web of Science ®Google Scholar
• Paroni G, Seripa D, Fontana A, et al. Klotho Gene and Selective Serotonin Reuptake Inhibitors: response to Treatment in Late-Life Major Depressive Disorder. Mol Neurobiol. 2017;54(2):1340–1351. .
   PubMed Web of Science ®Google Scholar
• Wong D, Bellyou M, Beauchet O, et al., Vitamin D supplementation may protect against oxidative stress in a vitamin D deficient double-transgenic mouse model of Alzheimer’s disease. Alzheimers Dement. 13(7S_Part_15): P 746–7. 2017. .
   Google Scholar
• Wimalawansa SJ. Vitamin D deficiency: effects on oxidative stress, epigenetics, gene regulation, and aging. Biology (Basel). 2019;8(2):30.
   PubMed Web of Science ®Google Scholar
• Buell JS, Dawson- HB. Vitamin D and neurocognitive dysfunction: preventing “D” ecline? Mol Aspects Med. 2008;29(6):415–422.
   PubMed Web of Science ®Google Scholar
• Groves NJ, Kesby JP, Eyles DW, et al. Adult vitamin D deficiency leads to behavioural and brain neurochemical alterations in C57BL/6J and BALB/c mice. Behav Brain Res. 2012;241:120–131.
   PubMed Web of Science ®Google Scholar
• Byrne JH, Voogt M, Turner KM, et al. The impact of adult vitamin D deficiency on behaviour and brain function in male sprague-dawley rats. PLoS One. 2013;8(8):e71593. .
   PubMed Web of Science ®Google Scholar
• Mehrabadi S, Sadr SS. Administration of Vitamin D and E supplements reduces neuronal loss‏ and oxidative stress in a model of rats with Alzheimer’s disease. Neurol Res. 2020;42(10):862–868.
   PubMed Web of Science ®Google Scholar
• Peng HB, Noh K, Pan SR, et al. Human Amyloid-β 40 kinetics after intravenous and intracerebroventricular injections and calcitriol treatment in rats in vivo. Drug Metab Dispos. 2020;48(10):944–955. .
   PubMed Web of Science ®Google Scholar
• Hu TM, Chung HS, Ping LY, et al. Differential Expression of Multiple Disease-Related Protein Groups Induced by Valproic Acid in Human SH-SY5Y Neuroblastoma Cells. Brain Sci. 2020;10(8):E545. .
   PubMed Web of Science ®Google Scholar
• Geng J, Zhang J, Yao F, et al. A systematic review and meta-analysis of the associations of vitamin D receptor genetic variants with two types of most common neurodegenerative disorders. Aging Clin Exp Res. 2020;32(1):21–27. .
   PubMed Web of Science ®Google Scholar
• Wang L, Qiao Y, Zhang H, et al. Circulating Vitamin D Levels and Alzheimer’s Disease: A Mendelian Randomization Study in the IGAP and UK Biobank. J Alzheimers Dis. 2020;73(2):609–618. .
   PubMed Web of Science ®Google Scholar
• Al-Amin M, Bradford D, Sullivan RKP, et al. Vitamin D deficiency is associated with reduced hippocampal volume and disrupted structural connectivity in patients with mild cognitive impairment. Hum Brain Mapp. 2019;40(2):394–406. .
   PubMed Web of Science ®Google Scholar
• Balion C, Griffith LE, Strifler L, et al., Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology. 79(13): 1397–1405. 2012. .
   PubMed Web of Science ®Google Scholar
• Goodwill AM, Campbell S, Jr SS, et al. Vitamin D status is associated with executive function a decade later: data from the Women’s healthy ageing project. Maturitas. 2018;107:56–62.
   PubMed Web of Science ®Google Scholar
• Granic A, Hill TR, Kirkwood TB, et al. Serum 25- hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+Study. Eur J Neurol. 2015;22(1):106–115. .
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281.
   PubMed Web of Science ®Google Scholar
• Kuzma E, Soni M, Littlejohns TJ, et al. Vitamin D and memory decline: two population based prospective studies. J Alzheimers Dis. 2016;50(4):1099–1108. .
   PubMed Web of Science ®Google Scholar
• Martyn CN, Singh S, Wood PJ. Calcium metabolism in Alzheimer’s disease. A Case-control Study. Gerontology. 1989;35:153–157.
   PubMed Web of Science ®Google Scholar
• Ferrier IN, Leake A, Taylor GA, et al. Reduced gastrointestinal absorption of calcium in dementia. Age Ageing. 1990;19(6):368–375. .
   PubMed Web of Science ®Google Scholar
• Kipen E, Helme RD, Wark JD, et al. Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia. J Am Geriatr Soc. 1995;43(10):1088–1091. .
   PubMed Web of Science ®Google Scholar
• Evatt ML, Delong MR, Khazai N, et al. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008;65(10):1348–1352. .
   PubMedGoogle Scholar
• Luckhaus C, Mahabadi B, Grass-Kapanke B, et al. Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer’s disease. J Neural Transm. 2009;116(7):905–911. .
   PubMed Web of Science ®Google Scholar
• Buell JS, Dawson-Hughes B, Scott TM, et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology. 2010;74(1):18–26. .
   PubMed Web of Science ®Google Scholar
• Annweiler C, Rolland Y, Schott AM, et al. Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: A 7-year longitudinal study. Dement Geriatr Cogn Disord. 2011;32(4):273–278. .
   PubMed Web of Science ®Google Scholar
• Afzal S, Bojesen SE, Nordestgaard BG. Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia. Alzheimers Dement. 2014;10(3):296–302.
   PubMed Web of Science ®Google Scholar
• Littlejohns TJ, Henley WE, Lang IA, et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology. 2014;83(10):920–928. .
   PubMed Web of Science ®Google Scholar
• Knekt P, Saaksjarvi K, Jarvinen R, et al. Serum 25-hydroxyvitamin d concentration and risk of dementia. Epidemiology. 2014;25:799–804.
   PubMed Web of Science ®Google Scholar
• Schneider AL, Lutsey PL, Alonso A, et al. Vitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC brain MRI study. Eur J Neurol. 2014;21(1211–8):e69–e70. .
   Google Scholar
• Graf CE, Rossi C, Giannelli SV, et al. Vitamin D is not associated with cognitive status in a cohort of very old hospitalized patients. J Alzheimers Dis. 2014;42(s3):S53–S61. .
   PubMedGoogle Scholar
• Moon JH, Lim S, Han JW, et al. Serum 25-hydroxyvitamin D level and the risk of mild cognitive impairment and dementia: the Korean Longitudinal Study on Health and Aging (KLoSHA). Clin Endocrinol (Oxf). 2015;83(1):36–42. .
   PubMed Web of Science ®Google Scholar
• Feart C, Helmer C, Merle B, et al. Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer’s disease in older adults. Alzheimers Dement. 2017;13(11):1207–1216. .
   PubMed Web of Science ®Google Scholar
• Licher S, RFAG DB, Wolters FJ, et al. Vitamin D and the Risk of Dementia: the Rotterdam Study. J Alzheimers Dis. 2017;60(3):989–997. .
   PubMed Web of Science ®Google Scholar
• Olsson E, Byberg L, Karlstrom B, et al. Vitamin D is not associated with incident dementia or cognitive impairment: an 18-y follow-up study in community-living old men. Am J Clin Nutr. 2017;105(4):936–943. .
   PubMed Web of Science ®Google Scholar
• Annweiler C, Llewellyn DJ, Beauchet O. Low serum vitamin D concentrations in Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2013;33(3):659–674.
   PubMed Web of Science ®Google Scholar
• Chai B, Gao F, Wu R, et al. Vitamin D deficiency as a risk factor for dementia and Alzheimer’s disease: an updated meta-analysis. BMC Neurol. 2019;19(1):284. .
   PubMed Web of Science ®Google Scholar
• Yang K, Chen J, Li X, et al. Vitamin D concentration and risk of Alzheimer disease: A meta-analysis of prospective cohort studies. Medicine (Baltimore). 2019;98(35):e16804. .
   PubMed Web of Science ®Google Scholar
• Jayedi A, Rashidy-Pour A, Shab- BS. Vitamin D status and risk of dementia and Alzheimer’s disease: A meta-analysis of dose-response. Nutr Neurosci. 2019;22(11):750–759.
   PubMed Web of Science ®Google Scholar
• Kalra A, Teixeira AL, Diniz BS. Association of vitamin d levels with incident all-cause dementia in longitudinal observational studies: a systematic review and meta-analysis. J Prev Alzheimers Dis. 2020;7(1):14–20. .
   PubMed Web of Science ®Google Scholar
• Goodwill AM, Campbell S, Simpson S, et al. Vitamin D status is associated with executive function a decade later: data from the Women’s Healthy Ageing Project. Maturitas. 2018;107:56–62.
   PubMed Web of Science ®Google Scholar
• Bartali B, Devore E, Grodstein F, et al. Plasma vitamin D levels and cognitive function in aging women: the nurses’ health study. J Nutr Heal Aging. 2014;18(4):400–406. .
   PubMed Web of Science ®Google Scholar
• Sommer I, Griebler U, Kien C, et al. Vitamin D deficiency as a risk factor for dementia: a systematic review and meta-analysis. BMC Geriatr. 2017;17(1):16. .
   PubMed Web of Science ®Google Scholar
• Miller JW, Harvey DJ, Beckett LA, et al. Vitamin D status and rates of cognitive decline in a multiethnic cohort of older adults. JAMA Neurol. 2015;72(11):1295–1303. .
   PubMed Web of Science ®Google Scholar
• Kelaiditi E, Guyonnet S, Cesari M. Is nutrition important to postpone frailty? Curr Opin Clin Nutr Metab Care. 2015;18(1):37–42.
   PubMed Web of Science ®Google Scholar
• Lorenzo-López L, Maseda A, de Labra C, et al. Nutritional determinants of frailty in older adults: A systematic review. BMC Geriatr. 2017;17(1):108. .
   PubMedGoogle Scholar
• Zupo R, Castellana F, Bortone I, et al. Nutritional domains in frailty tools: working towards an operational definition of nutritional frailty. Ageing Res Rev. 2020;64:101148.
   PubMed Web of Science ®Google Scholar
• Bales CW, Ritchie CS. Sarcopenia, weight loss, and nutritional frailty in the elderly. Annu Rev Nutr. 2002;22(1):309–323.
   PubMed Web of Science ®Google Scholar
• Kinney JM. Nutritional frailty, sarcopenia and falls in the elderly. Curr Opin Clin Nutr Metab Care. 2004;7(1):15–20.
   PubMed Web of Science ®Google Scholar
• Visser M, Deeg D, Lips P. Low vitamin d and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study amsterdam. J Clin Endocrinol Metab. 2003;88(12):5766–5772.
   PubMed Web of Science ®Google Scholar
• Marcos-Pérez D, Sánchez-Flores M, Proietti S, et al. Low vitamin d levels and frailty status in older adults: A systematic review and meta-analysis. Nutrients. 2020;12(8):E2286. .
   PubMed Web of Science ®Google Scholar
• Bartochowski Z, Conway J, Wallach Y, et al. Dietary Interventions to Prevent or Delay Alzheimer’s Disease: what the Evidence Shows. Curr Nutr Rep. 2020;9(3):210–225. .
   PubMedGoogle Scholar
• Dhesi JK, Jackson SHD, Bearne LM, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing. 2004;33(6):589–595. .
   PubMed Web of Science ®Google Scholar
• Przybelski R, Agrawal S, Krueger D, et al. Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int. 2008;19(11):1621–1628. .
   PubMed Web of Science ®Google Scholar
• Rossom RC, Espeland MA, Manson JE, et al. Calcium and vitamin supplementation and cognitive impairment in the women’s health initiative. J Am Geriatr Soc. 2012;60(12):2197–2205. .
   PubMed Web of Science ®Google Scholar
• Beydoun MA, Hossain S, Fanelli-Kuczmarski MT, et al. Vitamin D status and intakes and their association with cognitive trajectory in a longitudinal study of urban adults. J Clin Endocrinol Metab. 2018;103(4):1654–1668. .
   PubMed Web of Science ®Google Scholar
• Pettersen JA. Does high dose vitamin D supplementation enhance cognition? A randomized trial in healthy adults. Exp Gerontol. 2017;90:90–97.
   PubMed Web of Science ®Google Scholar
• Schietzel S, Fischer K, Brugger P, et al. Effect of 2000 IU compared with 800 IU vitamin D on cognitive performance among adults age 60 years and older: a randomized controlled trial. Am J Clin Nutr. 2019;110(1):246–253. .
   PubMed Web of Science ®Google Scholar
• Stein MS, Scherer SC, Ladd KS, et al. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer’s disease. J Alzheimers Dis. 2011;26(3):477–484. .
   PubMed Web of Science ®Google Scholar
• Jia J, Hu J, Huo X, et al. Effects of vitamin D supplementation on cognitive function and blood Abeta-related biomarkers in older adults with Alzheimer’s disease: a randomised, double-blind, placebo-controlled trial. J Neurol Neurosurg Psychiatry. 2019;90(12):1347–1352. .
   PubMed Web of Science ®Google Scholar
• Landel V, Annweiler C, Millet P, et al. Vitamin D, cognition and Alzheimer’s disease: the therapeutic benefit is in the D-tails. J Alzheimers Dis. 2016;53(2):419–444. .
   PubMed Web of Science ®Google Scholar
• Maddock J, Cavadino A, Power C, et al. 25-hydroxyvitamin D, APOE ɛ4 genotype and cognitive function: findings from the 1958 British birth cohort. Eur J Clin Nutr. 2015;69:505–508.
   PubMed Web of Science ®Google Scholar
• Soysal P, Dokuzlar O, Erken N, et al. The relationship between dementia subtypes and nutritional parameters in older adults. J Am Med Dir Assoc. 2020;21(10):1430–1435. .
   PubMed Web of Science ®Google Scholar
• Annweiler C, Beauchet O. Vitamin D-mentia: randomized clinical trials should be the next step. Neuroepidemiology. 2011;37(3–4):249–258.
   PubMed Web of Science ®Google Scholar
• Buell JS, Tucker KL. The value of physiologic vitamin D as a biomarker of dementia. Drugs Today (Barc). 2011;47(3):223–231.
   PubMed Web of Science ®Google Scholar
• Annweiler C, Souberbielle JC, Schott AM, et al. Vitamin D in the elderly: 5 points to remember. Geriatr Psychol Neuropsychiatr Vieil. 2011;9(3):259–267. .
   PubMed Web of Science ®Google Scholar
• Lozupone M, Seripa D, Stella E, et al. Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry. Expert Rev Proteomics. 2017;14(9):809–824. .
   PubMed Web of Science ®Google Scholar
• Gezen-Ak D, Dursun E. Molecular basis of vitamin D action in neurodegeneration: the story of a team perspective. Hormones (Athens). 2019;18(1):17–21.
   PubMedGoogle Scholar
• Palmer K, Monaco A, Kivipelto M, et al. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing. Aging Clin Exp Res. 2020;32(7):1189–1194. .
   PubMed Web of Science ®Google Scholar
• Pannu PK, Calton EK, Soares MJ. Calcium and vitamin D in obesity and related chronic disease. Adv Food Nutr Res. 2016;77:57–100.
   PubMedGoogle Scholar
• Meems LM, de Borst MH, Postma DS, et al. Low levels of vitamin D are associated with multimorbidity: results from the LifeLines Cohort Study. Ann Med. 2015;47(6):474–481. .
   PubMed Web of Science ®Google Scholar
• Vanherwegen A-S, Gysemans C, Mathieu C. Regulation of immune function by vitamin D and its use in diseases of immunity. Endocrinol Metab Clin N Am. 2017;46(4):1061–1094.
   PubMed Web of Science ®Google Scholar
• Girard TD, Self WH, Edwards KM, et al. Long-term cognitive impairment after hospitalization for community acquired pneumonia: a prospective cohort study. J Gen Intern Med. 2018;33(6):929–935. .
   PubMed Web of Science ®Google Scholar